We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Supernus’ Epilepsy Drug Oxtellar XR
FDA Approves Supernus’ Epilepsy Drug Oxtellar XR
October 26, 2012
The FDA has approved Supernus Pharmaceuticals’ Oxtellar XR as a once-daily therapy for epilepsy and the company plans to launch the drug next year.